Lupin gets Establishment Inspection Report from the USFDA for its Goa facility

The US drug regulator had inspected Lupin’s Goa facility, a key unit for the company, between November 10 and November 21, 2025.

Leave a Reply

Your email address will not be published. Required fields are marked *